Standard BioTools
(NASDAQ) SLGC
Standard BioTools Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$81.72M
Net Income (TTM)
$130.38M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SLGC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Standard BioTools
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
451
CEO
Roy Smythe, MD
Website
www.somalogic.comHeadquarters
Boulder, CO 80301, US
SLGC Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
-2%
Net Income Margin
-1%
Return on Equity
-19%
Return on Capital
-29%
Return on Assets
-17%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$54.30M
Operating Income
$175.76M
EBITDA
$175.76M
Operating Cash Flow
$100.67M
Capital Expenditure
$5.21M
Free Cash Flow
$105.88M
Cash & ST Invst.
$539.59M
Total Debt
$2.48M
Standard BioTools Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$22.05M
-47.1%
Gross Profit
$10.41M
-65.3%
Gross Margin
47.23%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
451
N/A
Net Income
$22.16M
+32.7%
EBITDA
$18.18M
+50.9%
Quarterly Fundamentals
Net Cash
$451.05M
-20.4%
Accounts Receivable
$20.73M
-17.2%
Inventory
$13.88M
-24.9%
Long Term Debt
$2.76M
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-16.86%
N/A
Return on Invested Capital
-29.10%
N/A
Free Cash Flow
$22.16M
+43.8%
Operating Cash Flow
$21.36M
+39.0%